Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Polymyxins: Implications for Therapeutic Use
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-030-16373-0_15
Reference129 articles.
1. Nation RL, Velkov T, Li J (2014) Colistin and polymyxin B: peas in a pod, or chalk and cheese? Clin Infect Dis 59:88–94. https://doi.org/10.1093/cid/ciu213
2. Gales AC, Jones RN, Sader HS (2011) Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006–09). J Antimicrob Chemother 66(9):2070–2074. https://doi.org/10.1093/jac/dkr239
3. Sader HS, Rhomberg PR, Farrell DJ, Jones RN (2015) Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide. Diagn Microbiol Infect Dis 83(4):379–381. https://doi.org/10.1016/j.diagmicrobio.2015.08.013
4. Kwa A, Kasiakou SK, Tam VH, Falagas ME (2007) Polymyxin B: similarities to and differences from colistin (polymyxin E). Expert Rev Anti-Infect Ther 5(5):811–821. https://doi.org/10.1586/14787210.5.5.811
5. Barnett M, Bushby SR, Wilkinson S (1964) Sodium sulphomethyl derivatives of polymyxins. Br J Pharmacol Chemother 23:552–574
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacokinetics and safety of colistin sulfate after single and multiple intravenous doses in healthy Chinese subjects;International Journal of Antimicrobial Agents;2024-09
2. New antibiotics in clinical pipeline for treating infections caused by metallo-β-lactamases producing Gram-negative bacteria;Current Opinion in Infectious Diseases;2024-08-01
3. A systematic evaluation of population pharmacokinetic models for polymyxin B in patients with liver and/or kidney dysfunction;Journal of Pharmacokinetics and Pharmacodynamics;2024-04-16
4. High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review;Microorganisms;2023-05-31
5. Treatment and diagnosis of severe KPC-producing Klebsiella pneumoniae infections: a perspective on what has changed over last decades;Annals of Medicine;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3